Hunan Jiudian Pharmaceutical have Ecovadis Bronze at the beginning of 2024
- Categories:News
- Author:
- Origin:
- Time of issue:2024-03-06
- Views:0
(Summary description)On March 1, 2024, Jiudian Hongyang Pharmaceutical, which is wholly-owned subsidiary of Jiudian Pharmaceutical, focus on production of APIs and excipients, have Ecovadis score for the first time, it is Bronze.
Hunan Jiudian Pharmaceutical have Ecovadis Bronze at the beginning of 2024
(Summary description)On March 1, 2024, Jiudian Hongyang Pharmaceutical, which is wholly-owned subsidiary of Jiudian Pharmaceutical, focus on production of APIs and excipients, have Ecovadis score for the first time, it is Bronze.
- Categories:News
- Author:
- Origin:
- Time of issue:2024-03-06
- Views:0
On March 1, 2024, Jiudian Hongyang Pharmaceutical, which is wholly-owned subsidiary of Jiudian Pharmaceutical, focus on production of APIs and excipients, have Ecovadis score for the first time, it is Bronze.
Our partners: Bayer, AstraZeneca, STADA and others very appreciate it.
After the comprehensive evaluation of the professional platform, the company has obtained international recognition in four aspects, including environmental protection and social responsibility, laying a solid foundation for cooperation with global pharmaceutical enterprises.
Jiudian harmaceutical will assume more and more social responsibilities.
Scan the QR code to read on your phone